Supplementary Figure S5 from Oxford Classic–Defined EMT Risk Stratification of High-Grade Serous Ovarian Cancer for Guiding Treatment Decisions
Rai L., Ravaggi A., Bignotti E., Hollis RL., Garsed DW., Pandey A., Papalois KB., Patel F., Kamel Y., Campo L., Easton A., Nulsen J., Roskams-Hieter B., Artibani M., Wang L., Hussain N., Wang L., Zaarour N., Aggarwal A., Ahmed-Ebbiary A., Al-Deka A., Churchman M., Herrington CS., Ardighieri L., Ferrari F., Yau C., Gourley C., Odicino F., Ahmed AA.
Supplementary Fig. S5. Representative images of an [A] OxC-EMT-high (patient BS137) and [B] OxC-EMT-low (patient BS141) tumour from the validation mIF experiments. [C] Violin plots demonstrating the difference in the abundance of M2 macrophages (CD206+ or CD206+CD163+) and CD8+TRM using immune cell counts normalised against total number of nuclei in each ROI.